0001567619-20-005034.txt : 20200227 0001567619-20-005034.hdr.sgml : 20200227 20200227173134 ACCESSION NUMBER: 0001567619-20-005034 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200225 FILED AS OF DATE: 20200227 DATE AS OF CHANGE: 20200227 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jooss Karin CENTRAL INDEX KEY: 0001754280 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38663 FILM NUMBER: 20664034 MAIL ADDRESS: STREET 1: C/O GRITSTONE ONCOLOGY, INC. STREET 2: 5858 HORTON STREET, SUITE 210 CITY: EMERYVILLE STATE: CA ZIP: 94608 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Gritstone Oncology, Inc. CENTRAL INDEX KEY: 0001656634 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5858 HORTON STREET, SUITE 210 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: (510) 871-6100 MAIL ADDRESS: STREET 1: 5858 HORTON STREET, SUITE 210 CITY: EMERYVILLE STATE: CA ZIP: 94608 4 1 doc1.xml FORM 4 X0306 4 2020-02-25 0 0001656634 Gritstone Oncology, Inc. GRTS 0001754280 Jooss Karin C/O GRITSTONE ONCOLOGY, INC. 5959 HORTON STREET, SUITE 300 EMERYVILLE CA 94608 0 1 0 0 See Remarks Stock Option (Right to Buy) 8.91 2020-02-25 4 A 0 110000 0 A 2020-04-01 2030-02-24 Common Stock 110000 110000 D The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on March 1, 2020. Executive Vice President and Chief Scientific Officer /s/ Jean-Marc Bellemin, Attorney-in-Fact for Karin Jooss 2020-02-27